Should We Synthesize A Human Genome?
By Drew Endy and Laurie Zoloth,
DSpace@MIT
| 05. 10. 2016
At Harvard today an invitation-only group of mostly scientists, lawyers, and entrepreneurs, ~150 in total, met to discuss if and how to synthesize from scratch an entire human genome – the heritable genetic material that in nature is transferred from parents to children. The meeting was originally organized to focus on “deliverables and industry involvement” with the primary goal of the project being “to synthesize a complete human genome in a cell line within a period of ten years.”
Synthesis refers to the construction of a genome starting from simple chemicals. Such a synthetic genome could then be tested in a laboratory by replacing the existing genome within a human cell. All this would still be far removed from making a synthetic human. However, the possibility of making a human cell whose genome is realized from only digital information and raw materials should trigger broader considerations.
...
Returning to our primary question, just because something becomes possible, how should we determine if it is ethical to proceed?
Continue reading at DSpace@MIT...
Image via Flikr/University of Michigan School of Natural...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...
